Patricio O'Donnell, M.D., Ph.D.

Patricio O'Donnell, M.D., Ph.D.
Patricio O'Donnell, M.D., Ph.D.

Executive Medical Director

Head of Neurocircuitry Modulation Biomarkers

Takeda Pharmaceuticals

Scientific Council Member (Joined 2007)

2010 Distinguished Investigator Grant

2003, 2001 Independent Investigator Grant

1995 Young Investigator Grant

Patricio O’Donnell combines an outstanding academic career in Neuroscience with experience in drug discovery and development for neuropsychiatric indications. He is an Executive Medical Director in the Translational Research and Early Clinical group at Takeda. Dr. O’Donnell grew up in Buenos Aires, Argentina and earned his M.D. and Ph.D. degrees from the University of Buenos Aires. Dr. O’Donnell worked as a postdoctoral fellow with Anthony Grace at the University of Pittsburgh, where he pioneered studies on the physiological properties of the nucleus accumbens, and then moved on to establishing his own research program at Albany Medical College. In 2006 he was recruited by the University of Maryland, and in 2013 he moved to Pfizer. He is the recipient of numerous awards including the 2010 National Alliance for Schizophrenia and Depression Distinguished Investigator Award. Dr. O’Donnell is a fellow in the American College of Neuropsychopharmacology (ACNP), chaired several conferences including the 2009 Gordon Conference on Catecholamines and the Winter Conference on Brain Research in 2012 and 2013. Dr. O’Donnell has authored over 100 scientific papers, served or serves on the Editorial Boards of the Journal of Neuroscience, Neuropsychopharmacology, The International Journal of Neuropsychopharmacology, Schizophrenia Bulletin, and the Journal of Pharmacology & Experimental Therapeutics, among others, and sat on advisory committees of the National Institutes of Health. He serves on the scientific advisory board of several private foundations and has advised major pharmaceutical and biotech companies. Before joining Takeda, Dr. O’Donnell led discovery efforts for Psychiatry and Pfizer and prior to that he was a Professor of Anatomy & Neurobiology and Psychiatry at the University of Maryland School of Medicine.

Learn More About the Foundation

We Are

The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.

Read more


Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.

Read more


Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.

Read More

Annual Report
& Financials

We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.

Read more


Frequently Asked Questions about the Brain & Behavior Research Foundation.

Read more


The latest news on brain and behavior research and issues that matter most to you.

Read more